Literature DB >> 21802735

Five-year follow-up study of disability pension rates in first-onset schizophrenia with special focus on regional differences and mortality.

Marjo Kiviniemi1, Jaana Suvisaari, Sami Pirkola, Kristian Läksy, Unto Häkkinen, Matti Isohanni, Helinä Hakko.   

Abstract

OBJECTIVE: To evaluate the rate and regional determinants of disability pension in first-admission schizophrenia. In addition, we investigated whether patients with disability pension had increased mortality rates during follow-up.
METHOD: A nationwide register-based 5-year follow-up study of all patients with onset of schizophrenia between 1998 and 2001 (n=3,875).
RESULTS: A total of 1944 (50.2%) first-onset schizophrenia patients retired on disability pension during the 5-year follow-up. Males retired on pension at an earlier age and more often than females. Regional disability pension rates and retirement times for schizophrenia varied between hospital districts. Patients on disability pension had lower overall and suicide mortality, and they had less physical illness, depression and more psychotropic medication use than patients without disability pension. In regions with a short median time from onset time to retirement, there was significantly higher regional overall mortality and suicide mortality. Disability pension rates were also higher in regions with high involuntary treatment rate.
CONCLUSION: Half of the schizophrenia patients were pensioned off in 5 years. Lower mortality, especially suicide mortality among disability pensioners, suggests that the decision on a permanent disability pension, indicating for its part the activation of the service system, might be a relief to schizophrenic patients, helping them cope with illness. The retirement process has regional differences, which may be caused by the regional nature of treatment and resources.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21802735     DOI: 10.1016/j.genhosppsych.2011.05.017

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  5 in total

1.  Employment trajectories until midlife in schizophrenia and other psychoses: the Northern Finland Birth Cohort 1966.

Authors:  Tuomas Majuri; Anni-Emilia Alakokkare; Marianne Haapea; Tanja Nordström; Jouko Miettunen; Erika Jääskeläinen; Leena Ala-Mursula
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-07-07       Impact factor: 4.328

2.  Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status.

Authors:  Marte Tandberg; Kjetil Sundet; Ole A Andreassen; Ingrid Melle; Torill Ueland
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-13       Impact factor: 4.328

3.  Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.

Authors:  Nancy H Liu; Gail L Daumit; Tarun Dua; Ralph Aquila; Fiona Charlson; Pim Cuijpers; Benjamin Druss; Kenn Dudek; Melvyn Freeman; Chiyo Fujii; Wolfgang Gaebel; Ulrich Hegerl; Itzhak Levav; Thomas Munk Laursen; Hong Ma; Mario Maj; Maria Elena Medina-Mora; Merete Nordentoft; Dorairaj Prabhakaran; Karen Pratt; Martin Prince; Thara Rangaswamy; David Shiers; Ezra Susser; Graham Thornicroft; Kristian Wahlbeck; Abe Fekadu Wassie; Harvey Whiteford; Shekhar Saxena
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients - a cross-sectional study.

Authors:  Kristyna Vrbova; Jan Prasko; Marie Ociskova; Michaela Holubova; Krystof Kantor; Antonin Kolek; Aleš Grambal; Milos Slepecky
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-01       Impact factor: 2.570

5.  Contribution of rare and common variants to intellectual disability in a sub-isolate of Northern Finland.

Authors:  Mitja I Kurki; Elmo Saarentaus; Olli Pietiläinen; Padhraig Gormley; Dennis Lal; Sini Kerminen; Minna Torniainen-Holm; Eija Hämäläinen; Elisa Rahikkala; Riikka Keski-Filppula; Merja Rauhala; Satu Korpi-Heikkilä; Jonna Komulainen-Ebrahim; Heli Helander; Päivi Vieira; Minna Männikkö; Markku Peltonen; Aki S Havulinna; Veikko Salomaa; Matti Pirinen; Jaana Suvisaari; Jukka S Moilanen; Jarmo Körkkö; Outi Kuismin; Mark J Daly; Aarno Palotie
Journal:  Nat Commun       Date:  2019-01-24       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.